A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age
Clinical trial NCT04796896 · COMPLETED
Trial details
- NCT number
- NCT04796896
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-15
- Primary completion
- 2024-03-15
- Enrollment
- 11942
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.